HEARX GROUP (PTY) LTD

HearX Group (Pty) Ltd specializes in air-conduction hearing aids, offering multiple form factors such as receiver-in-canal, behind-the-ear, and in-the-ear designs. Additionally, they develop audiometric and hearing device software, which supports hearing assessments and proprietary hearing solutions under their branded product lines.

HearX Group (Pty) Ltd operates from the United States, where it aligns its manufacturing and regulatory practices with U.S. standards for medical devices.

HearX Group’s devices are primarily listed in the FDA’s Unique Device Identifier (UDI) database, which is a central registry for tracking medical devices authorized under U.S. regulations.

HearX Group’s devices fall under two FDA classification categories: Class I and Class II. Class I devices generally pose minimal risk and may require less stringent regulatory oversight, while Class II devices involve moderate risk and require special controls to ensure safety and effectiveness.

The classification of HearX Group’s hearing aids—either Class I or Class II—depends on factors like the device’s intended use, potential risks, and the level of regulatory scrutiny required. For example, simpler hearing aids with low risk may qualify as Class I, while those with additional features or higher risk profiles (e.g., custom-fit or programmable devices) may be classified as Class II to ensure proper safety and performance standards are met.